Work

Piritrexim in Advanced, Refractory Carcinoma of the Urothelium (E3896): A Phase II Trial of the Eastern Cooperative Oncology Group

Year: 2002

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1020675017737

Authors: Bruce J. Roth, Judith Manola, Robert Dreicer, David Graham, George Wilding

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Dana-Farber Cancer Institute, Cleveland Clinic, Carle Foundation Hospital, University of Wisconsin–Madison

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Awards: ECOG Statistical Office Data Management Grant, G1422427855, G286468852, G3210846400, G4412485521, Eastern Cooperative Oncology Group, G721629745, Eastern Cooperative Oncology Group, EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES, ECOG Statistical Office, Eastern Cooperative Oncology Group Operations Office, G964706321

OpenAlex ID: W99289774

FWCI: 1.909

Cites: 21

Cited by: 33

Related to: 10